EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS - Asset Resilience Ratio
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (ECILC) has an Asset Resilience Ratio of 0.46% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check EIS Eczacibasi Ilac Sinai ve Finansal Ya PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's Asset Resilience Ratio has changed over time. See debt-free asset ratio of EIS Eczacibasi Ilac Sinai ve Finansal Ya to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EIS Eczacibasi Ilac Sinai ve Finansal Ya stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 0% |
| Short-term Investments | TL322.48 Million | 0.46% |
| Total Liquid Assets | TL322.48 Million | 0.46% |
Asset Resilience Insights
- Limited Liquidity: EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS Industry Peers by Asset Resilience Ratio
Compare EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 1.28% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Procter & Gamble Health Limited
NSE:PGHL |
Drug Manufacturers - Specialty & Generic | 33.01% |
Annual Asset Resilience Ratio for EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS (2000–2024)
The table below shows the annual Asset Resilience Ratio data for EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.53% | TL298.71 Million ≈ $6.69 Million |
TL56.20 Billion ≈ $1.26 Billion |
+0.05pp |
| 2023-12-31 | 0.48% | TL303.65 Million ≈ $6.80 Million |
TL62.80 Billion ≈ $1.41 Billion |
-1.19pp |
| 2022-12-31 | 1.67% | TL388.04 Million ≈ $8.69 Million |
TL23.23 Billion ≈ $520.33 Million |
-0.35pp |
| 2021-12-31 | 2.02% | TL166.59 Million ≈ $3.73 Million |
TL8.26 Billion ≈ $185.11 Million |
+1.60pp |
| 2020-12-31 | 0.42% | TL25.07 Million ≈ $561.59K |
TL5.97 Billion ≈ $133.72 Million |
+0.39pp |
| 2019-12-31 | 0.03% | TL1.25 Million ≈ $28.09K |
TL4.84 Billion ≈ $108.37 Million |
+0.00pp |
| 2018-12-31 | 0.03% | TL1.15 Million ≈ $25.67K |
TL4.46 Billion ≈ $99.81 Million |
+0.02pp |
| 2017-12-31 | 0.01% | TL354.00K ≈ $7.93K |
TL3.83 Billion ≈ $85.81 Million |
-0.02pp |
| 2016-12-31 | 0.03% | TL1.08 Million ≈ $24.23K |
TL3.99 Billion ≈ $89.43 Million |
-0.03pp |
| 2015-12-31 | 0.06% | TL2.06 Million ≈ $46.25K |
TL3.37 Billion ≈ $75.48 Million |
+0.04pp |
| 2014-12-31 | 0.02% | TL763.00K ≈ $17.09K |
TL3.26 Billion ≈ $73.09 Million |
+0.01pp |
| 2013-12-31 | 0.01% | TL308.00K ≈ $6.90K |
TL3.44 Billion ≈ $76.98 Million |
0.00pp |
| 2012-12-31 | 0.01% | TL372.00K ≈ $8.33K |
TL3.48 Billion ≈ $77.94 Million |
-0.04pp |
| 2011-12-31 | 0.05% | TL1.40 Million ≈ $31.45K |
TL3.03 Billion ≈ $67.90 Million |
-0.08pp |
| 2010-12-31 | 0.13% | TL3.42 Million ≈ $76.58K |
TL2.66 Billion ≈ $59.63 Million |
-0.20pp |
| 2009-12-31 | 0.33% | TL8.17 Million ≈ $182.99K |
TL2.49 Billion ≈ $55.75 Million |
-0.40pp |
| 2008-12-31 | 0.73% | TL14.82 Million ≈ $332.04K |
TL2.02 Billion ≈ $45.33 Million |
-0.71pp |
| 2005-12-31 | 1.44% | TL18.77 Million ≈ $420.31K |
TL1.30 Billion ≈ $29.14 Million |
-2.00pp |
| 2004-12-31 | 3.44% | TL29.52 Million ≈ $661.13K |
TL858.48 Million ≈ $19.23 Million |
+3.44pp |
| 2003-12-31 | 0.00% | TL7.99 Billion ≈ $178.96 Million |
TL739.70 Trillion ≈ $16.57 Trillion |
-4.26pp |
| 2002-12-31 | 4.26% | TL11.19 Trillion ≈ $250.52 Billion |
TL262.36 Trillion ≈ $5.88 Trillion |
-0.48pp |
| 2001-12-31 | 4.74% | TL8.29 Trillion ≈ $185.77 Billion |
TL174.96 Trillion ≈ $3.92 Trillion |
-3.61pp |
| 2000-12-31 | 8.35% | TL10.58 Trillion ≈ $236.87 Billion |
TL126.63 Trillion ≈ $2.84 Trillion |
-- |
About EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment develops real estate properties; engages… Read more